TY - JOUR A1 - Kopinski, Stephan A1 - Engel, Tilman A1 - Cassel, Michael A1 - Fröhlich, Katja A1 - Mayer, Frank A1 - Carlsohn, Anja T1 - Ultrasound Applied to Subcutaneous Fat Tissue Measurements in International Elite Canoeists JF - International journal of sports medicine N2 - Subcutaneous adipose tissue (SAT) measurements with ultrasound have recently been introduced to assess body fat in elite athletes. However, appropriate protocols and data on various groups of athletes are missing. We investigated intra-rater reliability of SAT measurements using ultrasound in elite canoe athletes. 25 international level canoeists (18 male, 7 female; 23 +/- 4 years; 81 +/- 11 kg; 1.83 +/- 0.09 m; 20 +/- 3 training h/wk) were measured on 2 consecutive days. SAT was assessed with B-mode ultrasound at 8 sites (ISAK): triceps, subscapular, biceps, iliac crest, supraspinal, abdominal, front thigh, medial calf, and quantified using image analysis software. Data was analyzed descriptively (mean +/- SD, [range]). Coefficient of variation (CV %), intraclass correlation coefficient (ICC, 2.1) and absolute (LoA) and ratio limits of agreement (RLoA) were calculated for day-to-day reliability. Mean sum of SAT thickness was 30.0 +/- 19.4 mm [8.0, 80.1 mm], with 3.9 +/- 1.8 mm [1.2 mm subscapular, 8.0 mm abdominal] for individual sites. CV for the sum of sites was 4.7 %, ICC 0.99, LoA 1.7 +/- 3.6 mm, RLoA 0.940 (*/divided by 1.155). Measuring SAT with ultrasound has proved to have excellent day-to-day reliability in elite canoe athletes. Recommendations for standardization of the method will further increase accuracy and reproducibility. KW - subcutaneous adipose tissue KW - skinfold thickness KW - elite athletes KW - body composition KW - ultrasonography Y1 - 2015 U6 - https://doi.org/10.1055/s-0035-1555857 SN - 0172-4622 SN - 1439-3964 VL - 36 IS - 14 SP - 1134 EP - 1141 PB - Thieme CY - Stuttgart ER - TY - JOUR A1 - Ghods, Mojtaba A1 - Georgiou, Iakovos A1 - Schmidt, Jeremias A1 - Kruppa, Philipp T1 - Disease progression and comorbidities in lipedema patients BT - a 10-year retrospective analysis JF - Dermatologic therapy N2 - Multiple associated comorbidities have been described for lipedema patients. Disease diagnosis still remains challenging in many cases and is frequently delayed. The purpose of this study was to determine the most common comorbidities in lipedema patients and the impact of surgical treatment onto disease progression. A retrospective assessment of disease-related epidemiologic data was performed for patients who underwent liposuction between July 2009 and July 2019 in a specialized clinic for lipedema surgery. All patients received a standardized questionnaire regarding the clinical history and changes of lipedema-associated symptoms and comorbidities after surgery. 106 patients who underwent a total of 298 liposuction procedures were included in this study after returning the questionnaire fully filled-in. Multiple comorbidities were observed in the assessed collective. The prevalence for obesity, hypothyroidism, migraine, and depression were markedly increased in relation to comparable nonlipedema populations. Despite a median body mass index (BMI) of 31.6 kg/m(2) (IQR 26.4-38.8), unexpected low prevalence of diabetes (5%) and dyslipidemia (7%) was found. Diagnosis and initiation of guideline-appropriate treatment were delayed by years in many patients. After surgical treatment (medium follow-up 20 months, IQR 11-42), a significant reduction of lipedema-associated symptoms was demonstrated. Lipedema occurs with a diversity of associated comorbidities. Therefore, on the basis of available data, the authors suggest the necessity of a multimodal therapy concept for a comprehensive and holistic treatment. Despite a commonly increased BMI, lipedema patients appear to have an advantageous metabolic risk profile. KW - comorbidities KW - epidemiology KW - lipedema KW - lipoedema KW - subcutaneous adipose tissue Y1 - 2020 U6 - https://doi.org/10.1111/dth.14534 SN - 1529-8019 VL - 33 IS - 6 PB - Wiley-Blackwell CY - Oxford ER -